# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001485003-23-000031
Filing Date
2023-02-07
Accepted
2023-02-07 16:29:29
Documents
15
Period of Report
2023-02-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | sesn-20230207.htm iXBRL | 8-K | 54973
2 | EX-99.1 | exhibit991_carismaprguey.htm | EX-99.1 | 7880
6 |  | exhibit991_carismaprguey001.jpg | GRAPHIC | 264724
7 |  | exhibit991_carismaprguey002.jpg | GRAPHIC | 302577
| Complete submission text file | 0001485003-23-000031.txt |  | 994958

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | sesn-20230207.xsd | EX-101.SCH | 1902
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | sesn-20230207_lab.xml | EX-101.LAB | 24849
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | sesn-20230207_pre.xml | EX-101.PRE | 13046
9 | EXTRACTED XBRL INSTANCE DOCUMENT | sesn-20230207_htm.xml | XML | 11848

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 23595448
SIC: 2834 Pharmaceutical Preparations